Paper Details

  1. Home
  2. Paper Details

Adjuvant (post-surgery) chemotherapy for early stage epithelial ovarian cancer.

Author: KitchenerHenry C, LawrieTheresa A, Winter-RoachBrett A

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Meta-AnalysisA statistical technique that integrates the results of multiple studies to draw more general conclusions about a particular issue.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.
Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.

Overview

Epithelial ovarian cancer is a serious condition affecting thousands of women in the UK each year. Only 10-15% are diagnosed early when treatment is most effective. While platinum-based chemotherapy after surgery has shown improved survival in large trials, the best approach for different groups of women with varying prognoses is still being determined.
Paper Details　
Original Abstract of the Article :
Epithelial ovarian cancer is diagnosed in 4500 women in the UK each year of whom 1700 will ultimately die of their disease.Of all cases 10% to 15% are diagnosed early when there is still a good possibility of cure. The treatment of early stage disease involves surgery to remove disease often followe...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/22419298

データ提供：米国国立医学図書館（NLM）

Adjuvant Chemotherapy for Early Stage Epithelial Ovarian Cancer: A Complex Decision

Epithelial ovarian cancer is a challenging disease, and early diagnosis is crucial for improving outcomes. This study explores the role of [adjuvant chemotherapy] in the treatment of early stage epithelial ovarian cancer, examining the evidence for its effectiveness in improving overall survival. Researchers review the results of large clinical trials, highlighting the potential benefits of adjuvant platinum-based chemotherapy while acknowledging the need for further research to clarify its optimal use in different subgroups of patients.

Adjuvant Chemotherapy: A Potential Benefit for Early Stage Ovarian Cancer

This study provides evidence that [adjuvant chemotherapy] may improve overall survival in patients with early stage epithelial ovarian cancer. However, the study also highlights the importance of individualizing treatment based on patient characteristics and prognosis. These findings underscore the need for careful consideration of the potential benefits and risks of adjuvant chemotherapy in making treatment decisions for early stage ovarian cancer.

Navigating Ovarian Cancer Treatment

Ovarian cancer diagnosis can be a challenging experience. This study emphasizes the importance of working closely with a qualified healthcare team to make informed treatment decisions. If you are diagnosed with ovarian cancer, open communication with your doctor and access to comprehensive information are essential for making the best choices for your health.

Dr. Camel's Conclusion

Just like the desert, which can be treacherous but also holds hidden oases, the journey of ovarian cancer treatment requires careful navigation. This study sheds light on the complexities of adjuvant chemotherapy, emphasizing the need for a collaborative approach between patient and physician to ensure optimal outcomes.

Date :
  1. Date Completed 2012-06-07
  2. Date Revised 2021-10-21
Further Info :

Pubmed ID

22419298

DOI: Digital Object Identifier

EMS57371

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.